Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for EYPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 -20.18M
March 31, 2026 -1.128M
December 31, 2025 -166.71M
September 30, 2025 -7.563M
June 30, 2025 -0.273M
March 31, 2025 -0.593M
December 31, 2024 -152.08M
September 30, 2024 -12.04M
June 30, 2024 -0.625M
March 31, 2024 -4.56M
December 31, 2023 -218.52M
September 30, 2023 -10.78M
June 30, 2023 -0.005M
March 31, 2023 -0.248M
December 31, 2022 -0.599M
September 30, 2022 0.445M
June 30, 2022 0.00
March 31, 2022 -0.241M
December 31, 2021 -108.56M
September 30, 2021 -0.047M
June 30, 2021 0.329M
March 31, 2021 -108.92M
December 31, 2020 -25.12M
September 30, 2020 -4.919M
June 30, 2020 0.295M
Date Value
March 31, 2020 -20.47M
December 31, 2019 -1.978M
September 30, 2019 -2.412M
June 30, 2019 -18.39M
March 31, 2019 -0.264M
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 0.00
June 30, 2017 -6.099M
March 31, 2017 -2.395M
December 31, 2016 0.00
September 30, 2016 -0.009M
June 30, 2016 -0.122M
March 31, 2016 -16.53M
December 31, 2015 -0.329M
September 30, 2015 -0.009M
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 -0.179M
September 30, 2014 -0.056M
June 30, 2014 0.014M
March 31, 2014 -7.457M
December 31, 2013 -1.62M
September 30, 2013 -9.981M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Ocular Therapeutix, Inc. -2.581M
Eli Lilly & Co. 1.601B
Elanco Animal Health, Inc. 0.00
Amylyx Pharmaceuticals, Inc. -1.973M
Nuvation Bio, Inc. -4.748M